Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics, Inc.

ARTV

Rank in Stocks #16537
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm... Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and various forms of cancer. Its flagship therapeutic candidate, AB-101, is an innovative, ready-to-use (off-the-shelf) NK cell therapy. This treatment is being developed for a broad spectrum of conditions, including autoimmune diseases like lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, systemic lupus erythematosus, and specific anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes such as granulomatosis with polyangiitis/microscopic polyangiitis, in addition to B-cell non-Hodgkin lymphoma. The company's pipeline also includes AB-201, an allogeneic anti-human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell candidate, and AB-205, another allogeneic anti-CD5 CAR-NK cell candidate. Established in 2019, Artiva Biotherapeutics is headquartered in San Diego, California.
Share Price
$3.86
Last synced: 2026-11-17
Market Cap
$197.64M
Change (1 day)
-2.53%
Change (1 year)
23.32%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Artiva Biotherapeutics, Inc. (ARTV)

Category

Healthcare
Operating Margin for Artiva Biotherapeutics, Inc. (ARTV)
Operating Margin as of November 2026 TTM: 0.00%
According to Artiva Biotherapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Artiva Biotherapeutics, Inc. from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% -100.00%
2024 -26,805.58% 29,170.12%
2023 -91.58% -92.45%
2022 -1,213.32% -54.40%
2021 -2,660.94% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Artiva Biotherapeutics, Inc.'s operating margin

What was Artiva Biotherapeutics, Inc.'s operating margin in 2025?

In 2025, Artiva Biotherapeutics, Inc.'s operating margin was 0.00%, compared with -26,805.58% in 2024.

How has Artiva Biotherapeutics, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Artiva Biotherapeutics, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-26,805.58%).

How does Artiva Biotherapeutics, Inc.'s operating margin compare with similar companies?

Artiva Biotherapeutics, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.